MARKET

FEMY

FEMY

FEMASYS INC
NASDAQ
0.3806
-0.0008
-0.21%
After Hours: 0.3900 +0.0094 +2.47% 19:31 05/14 EDT
OPEN
0.3841
PREV CLOSE
0.3814
HIGH
0.3855
LOW
0.3704
VOLUME
134.64K
TURNOVER
--
52 WEEK HIGH
1.130
52 WEEK LOW
0.3067
MARKET CAP
22.98M
P/E (TTM)
-0.8081
1D
5D
1M
3M
1Y
5Y
1D
Femasys updates corporate presentation on women’s health portfolio
TipRanks · 1d ago
Analysts Offer Insights on Healthcare Companies: Femasys (FEMY) and Protara Therapeutics (TARA)
TipRanks · 1d ago
Femasys announces CE Mark approval for FemHSG Catheter
TipRanks · 1d ago
Femasys Announces CE Mark Approval For FemHSG Catheter, Further Expanding Its Portfolio In Europe Through Commercial Partners
Benzinga · 1d ago
FEMASYS EXPANDS FERTILITY CARE PORTFOLIO IN EUROPE WITH CE MARK APPROVAL FOR FEMHSG™ CATHETER
Reuters · 1d ago
Femasys wins CE Mark approval for FemHSG catheter in Europe
PUBT · 1d ago
Lake Street Remains a Buy on Femasys (FEMY)
TipRanks · 2d ago
Weekly Report: what happened at FEMY last week (0504-0508)?
Weekly Report · 3d ago
More
About FEMY
Femasys Inc. is a biomedical company. The Company is focused on addressing the unmet needs of women worldwide with a broad portfolio of in-office, accessible, and therapeutic and diagnostic solutions. The Company has two lead product candidates: FemBloc and FemaSeed. FemBloc is a permanent birth control solution in development. Its permanent birth control solution in development includes its FemBloc system, which features dual intrauterine directional delivery targeting both fallopian tubes with a degradable blended biopolymer. FemaSeed is an artificial insemination infertility treatment. Its artificial insemination solution in development includes its FemaSeed product candidate for artificial insemination, which features single intrauterine directional delivery. It also developed FemCerv, which is an endocervical tissue sampler for cervical cancer diagnosis; FemVue, which is a companion diagnostic for fallopian tube assessment; FemCath, which is an intrauterine catheter, and FemChec.

Webull offers Femasys Inc stock information, including NASDAQ: FEMY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FEMY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading FEMY stock methods without spending real money on the virtual paper trading platform.